Guided Therapeutics, Inc. , the maker of the LuViva Advanced Cervical Scan, announced today that a group of prominent cervical cancer doctors are in the final stages of completing the clinical data...
Olive Resource Capital Inc. is pleased to provide investors an updated, unaudited Net Asset Value per share. Management has estimated the NAV of the Company at C$0.064 per share for December 31,...
Olive Resource Capital Inc. is pleased to provide investors an updated, unaudited Net Asset Value per share. Management has estimated the NAV of the Company at C$0.064 per share for November 30,...
Olive Resource Capital Inc. is pleased to provide investors an updated, unaudited Net Asset Value per share. Management has estimated the NAV of the Company at C$0.066 per share for September 30,...
Guided Therapeutics, Inc. or the “Company” , the maker of LuViva, a rapid and painless cervical cancer detection system based on the Company’s patented biophotonic technology,... | May 1, 2023
Guided Therapeutics, Inc. or the “Company” , the maker of LuViva, a rapid and painless cervical cancer detection system based on the Company’s patented biophotonic technology,... | December 21, 2022
/PRNewswire/ -- Data Bridge Market Research has recently published a Report, titled, "Cervical Cancer Diagnostic Market" The report offers an extensive...
/PRNewswire/ -- The "Cervical Dysplasia Market Research Report by Diagnostics Type, by Treatment Type, by End User, by Region - Global Forecast to 2027 -...
SAN FRANCISCO, Sept. 7, 2021 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today
Lawmakers Spar Over Infrastructure Package as Deadline Nears WASHINGTON-Lawmakers sparred Monday over Senate Democrats' decision to impose a midweek deadline on a bipartisan group still...